Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out
March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Tuesday, April 18, 2017

Webinar: Causes of Variability in TMA Odor Intensity


"Causes of Variabaility in TMA Odor Intensity"

by Yiran Guo, PhD.
George Preti, PhD.

This is the 2nd part (George Preti, PhD) of a joint webinar by Yiran Guo, PhD, and George Preti, PhD, of Monell Chemical Senses Center in Philadelphia", sponsored by RareConnect. In this webinar, they discuss the latest overview of TMAU, including the finding of the results of their genetic study on TMAU, "Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing."

This study indicates that 3 genes, PYROXD2, CP, and TXNDC2, in addition to the commonly known FMO3 gene contribute to Primary TMAU. This study was funded with $26,000 raised by sufferers of TMAU. These results suggest that there is still much more to be researched to discover all the genetic mutation, and their interactions with each other, that can contribute to Primary TMAU symptoms.

The first part of this webinar by Dr. Yiran Guo had technical problems and is being worked on by the RareConnect staff.

We thank Marta Campabadal with Eurordis / RareConnect for providing the platform for this webinar to take place.

get New Posts by EMAIL : Enter your email address :

A EURORDIS and NORD Member Organization


Post a Comment